newsmail.wyanokegroup.com/t...
We've heard this for years. These researchers have now confirmed and enlarged the risk profile. If the old conception was that chemotherapy was the culprit. This belief was partially responsible for the aversion to treatment. Their study shows comparatively little difference in risk between treated patients and never treated.
Skin cancer for sure, but breast, lung, and many more. If there's a message for us here is know the risks you came in with prior to your CLL diagnosis and keep a watchful eye on those, but add the ones mentioned in your screenings.
I just returned from Rochester ny, my tie up and confirm visit to my central, or lead CLL Doctor. I have two other hematology doctors for CLL and three more who watch, treat and follow up my skin, mandibular/oral cancer and most recently lung cancer . Dr ZENT was at mayo when I first started with him. He's now got an entire lab dedicated to CLL research at the Wilmot cancer center in Rochester ny. He's is one of the leading CLL research doctors we have
Dr ZENT is very thorough. And his physical exam is long and covers every area, skin, muscle tone, checks for fluid retention, feet, hands, mouth, ears scalp etc. the most thorough physical I get from anyone and that's with no blood work I brought a full batch of those from the recent past And he regularly gets updates from my local hematologist oncologist . Throughout the whole exam he stressed the "other"cancers
I left with a list of to do's... Of course he sends an exhaustive report to my other doctors.
One of the most frustrating parts of acquiring other cancers is they nearly always exclude you from participation in a trial .
second on my list of frustrations is that many if not most of the other cancer doctors view CLL as sligtyly worse than athletes foot. The old "good cancer" comes to mind as does the avoidance of treatment which probably led to the "good cancer". It's true that those with the more aggressive or potentially dangerous types of CLL is statistically smaller than the indolent types, but CLL can change and as newer less costly wide array genetic testing becomes more standard and cones into wider use that may change. The wrong impression of CLL ? That may be our job to teach our doctors.
So, now, something to do while in watch and wait
May good news be yours
Beth